The aim of this study is to investigate the association between serum TIM-3 (sTIM-3) levels and the stage of HCC and identify any correlations between the levels of sTIM-3 and serum PD-L1 (sPD-L1). Here, CD274 is linked to hepatocellular carcinoma.